Catabasis Pharma (CATB) Surges 50% on Deal with Serepta (SRPT)

September 29, 2016 9:47 AM EDT Send to a Friend

Catabasis Pharma (NASDAQ: CATB) is surging 49% in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Catabasis Pharma (CATB) Surges 50% on Deal with Serepta (SRPT)

Member Login

Free News Feed